scholarly journals Recent advances of novel technologies for quality consistency assessment of natural herbal medicines and preparations

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Xi-Chuan Wei ◽  
Bo Cao ◽  
Chuan-Hong Luo ◽  
Hao-Zhou Huang ◽  
Peng Tan ◽  
...  
2018 ◽  
Vol 9 ◽  
Author(s):  
Jiyao Sheng ◽  
Xiaohan Zou ◽  
Ziqian Cheng ◽  
Yien Xiang ◽  
Wei Yang ◽  
...  

2015 ◽  
Vol 30 (3) ◽  
pp. 320-323 ◽  
Author(s):  
Krystal Lansdowne ◽  
Christopher G. Scully ◽  
Loriano Galeotti ◽  
Suzanne Schwartz ◽  
David Marcozzi ◽  
...  

AbstractIn 2010, the US Food and Drug Administration (Silver Spring, Maryland USA) created the Medical Countermeasures Initiative with the mission of development and promoting medical countermeasures that would be needed to protect the nation from identified, high‐priority chemical, biological, radiological, or nuclear (CBRN) threats and emerging infectious diseases. The aim of this review was to promote regulatory science research of medical devices and to analyze how the devices can be employed in different CBRN scenarios. Triage in CBRN scenarios presents unique challenges for first responders because the effects of CBRN agents and the clinical presentations of casualties at each triage stage can vary. The uniqueness of a CBRN event can render standard patient monitoring medical device and conventional triage algorithms ineffective. Despite the challenges, there have been recent advances in CBRN triage technology that include: novel technologies; mobile medical applications (“medical apps”) for CBRN disasters; electronic triage tags, such as eTriage; diagnostic field devices, such as the Joint Biological Agent Identification System; and decision support systems, such as the Chemical Hazards Emergency Medical Management Intelligent Syndromes Tool (CHEMM-IST). Further research and medical device validation can help to advance prehospital triage technology for CBRN events.LansdowneK, ScullyCG, GaleottiL, SchwartzS, MarcozziD, StraussDG. Recent advances in medical device triage technologies for chemical, biological, radiological, and nuclear events. Prehosp Disaster Med. 2015;30(3):1-4


Fitoterapia ◽  
2013 ◽  
Vol 84 ◽  
pp. 273-285 ◽  
Author(s):  
Xu-zhao Li ◽  
Shuai-nan Zhang ◽  
Shu-min Liu ◽  
Fang Lu

Author(s):  
Toby B. Mehl-Schneider

With the increased development of mobile technologies, such as smartphones and tablets (i.e. iPhone, iPad), the field of augmentative and alternative communication (AAC) has changed rapidly over the last few years. Recent advances in technology have introduced applications (apps) for AAC purposes. These novel technologies could provide numerous benefits to individuals with complex communication needs. Nevertheless, introducing mobile technology apps is not without risk. Since these apps can be purchased and retrieved with relative ease, AAC assessments and collaborative evaluations have been circumvented in favor of the “quick fix”-simply ordering a random app for a potential user, without fully assessing the individual's needs and abilities. There is a paucity of research pertaining to mobile technology use in AAC. Therapists, parents and developers of AAC applications must work collaboratively to expand the research pertaining to the assessment and treatment of children who utilize AAC mobile technologies for communication purposes.


2008 ◽  
Vol 3 (1) ◽  
pp. 9 ◽  
Author(s):  
Zhongda Zeng ◽  
Foo-tim Chau ◽  
Hoi-yan Chan ◽  
Chui-yee Cheung ◽  
Tsui-yan Lau ◽  
...  

2012 ◽  
Vol 8 (8) ◽  
pp. 973-984 ◽  
Author(s):  
Chrisna Gouws ◽  
Dewald Steyn ◽  
Lissinda Du Plessis ◽  
Jan Steenekamp ◽  
Josias H Hamman

2016 ◽  
pp. 2236-2248
Author(s):  
Toby B. Mehl-Schneider

With the increased development of mobile technologies, such as smartphones and tablets (i.e. iPhone, iPad), the field of augmentative and alternative communication (AAC) has changed rapidly over the last few years. Recent advances in technology have introduced applications (apps) for AAC purposes. These novel technologies could provide numerous benefits to individuals with complex communication needs. Nevertheless, introducing mobile technology apps is not without risk. Since these apps can be purchased and retrieved with relative ease, AAC assessments and collaborative evaluations have been circumvented in favor of the “quick fix”-simply ordering a random app for a potential user, without fully assessing the individual's needs and abilities. There is a paucity of research pertaining to mobile technology use in AAC. Therapists, parents and developers of AAC applications must work collaboratively to expand the research pertaining to the assessment and treatment of children who utilize AAC mobile technologies for communication purposes.


2015 ◽  
Vol 2015 ◽  
pp. 1-12 ◽  
Author(s):  
Zhiming Li ◽  
Jihong Sun ◽  
Xiaoming Yang

Liver fibrosis is a life-threatening disease with high morbidity and mortality owing to its diverse causes. Liver biopsy, as the current gold standard for diagnosing and staging liver fibrosis, has a number of limitations, including sample variability, relatively high cost, an invasive nature, and the potential of complications. Most importantly, in clinical practice, patients often reject additional liver biopsies after initiating treatment despite their being necessary for long-term follow-up. To resolve these problems, a number of different noninvasive imaging-based methods have been developed for accurate diagnosis of liver fibrosis. However, these techniques only reflect morphological or perfusion-related alterations in the liver, and thus they are generally only useful for the diagnosis of late-stage liver fibrosis (liver cirrhosis), which is already characterized by “irreversible” anatomic and hemodynamic changes. Thus, it is essential that new approaches are developed for accurately diagnosing early-stage liver fibrosis as at this stage the disease may be “reversed” by active treatment. The development of molecular MR imaging technology has potential in this regard, as it facilitates noninvasive, target-specific imaging of liver fibrosis. We provide an overview of recent advances in molecular MR imaging for the diagnosis and staging of liver fibrosis and we compare novel technologies with conventional MR imaging techniques.


Sign in / Sign up

Export Citation Format

Share Document